P2-222: Can the patients with locally advanced non-small...

P2-222: Can the patients with locally advanced non-small cell lung cancer (LANSCLC) tolerate 60mg/m2 docetaxel on day 1 and 30mg/m2 Cisplatin on day 1 and 2 for 2 cycles during concurrent radiotherapy (CCRT) after 2-3 cycles of induction chemotherapy?

Yu, Rong, Zhu, Guangying, Shi, Anhui
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
2
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1097/01.JTO.0000283930.30872.6b
Date:
August, 2007
File:
PDF, 314 KB
english, 2007
Conversion to is in progress
Conversion to is failed